Home

Invest with us

Quick access to platform and ratings, forms, PDS and TMD

Investor portal

Access all forms, offer documents and Target Market Determinations

Existing investor access

Register for access to the web portal

View listed holdings in PIXX or PAXX

Existing adviser access

Invest online

You can invest right now with our simple, secure online application

Invest online

Platform availability and Research ratings

Key documents

Platinum International Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum International Fund Active ETF (ASX:PIXX)
Product Disclosure Statement (PDS)
Target Market Determination (TMD)
Fees and Costs
Platinum Asia Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum Asia Fund Complex ETF (ASX:PAXX)
Product Disclosure Statement (PDS)
Target Market Determination (TMD)
Fees and Costs
Platinum Japan Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum European Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum International Technology Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum International Brands Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum International Health Sciences Fund
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs
Platinum Global Fund (Long Only)
Product Disclosure Statement (PDS)
Target Market Determination (TMD) - C Class
Target Market Determination (TMD) - P Class
Additional Investment form
Update my details
Switch an investment
Transfer an investment
Withdrawal requests
Authorise someone to access my account (individual representative)
Authorise someone to access my account (corporate representative)
Fees and Costs

Platinum Trust documents

Download
May 2026
April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025

Continuous disclosure

Zenith
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating assigned to Platinum International Fund (27 November 2025), Platinum Asia Fund (13 November 2025), Platinum Japan Fund (13 November 2025), Platinum European Fund (13 November 2025), Platinum International Technology Fund (13 November 2025), Platinum International Brands Fund (13 November 2025), Platinum International Health Sciences Fund (13 November 2025), Platinum Global Fund (Long Only) (13 November 2025), referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

Lonsec
The ratings issued for Platinum International Fund (January 2026), Platinum Asia Fund (February 2026), Platinum Japan Fund (April 2026), Platinum European Fund (April 2026), Platinum International Technology Fund (April 2026), Platinum International Brands Fund (April 2026), Platinum International Health Sciences Fund (April 2026), Platinum Global Fund (Long Only) (January 2026) are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. Copyright 2023 Lonsec. All rights reserved.